Pregled bibliografske jedinice broj: 1046448
Diagnostic potential of cerebrospinal fluid biomarkers in Alzheimer's disease combined with tau genotypes
Diagnostic potential of cerebrospinal fluid biomarkers in Alzheimer's disease combined with tau genotypes // Federation of European Neuroscience Societies Regional Meeting
Pečuh, Mađarska, 2017. str. 19-19 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1046448 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Diagnostic potential of cerebrospinal fluid biomarkers in Alzheimer's disease combined with tau genotypes
Autori
Babić Leko, Mirjana ; Willumsen, Nanet ; Nikolac Perković, Matea ; Klepac, Nataša ; Borovečki, Fran ; Hof, Patrick R. ; Pivac, Nela ; de Silva, Rohan ; Šimić, Goran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
Federation of European Neuroscience Societies Regional Meeting
Mjesto i datum
Pečuh, Mađarska, 20.09.2017. - 23.09.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Alzheimer's disease ; biomarkers ; cerebrospinal fluid ; genetic predisposition to disease ; single-nucleotide polymorphism ; tau proteins ; tau haplotypes
Sažetak
Alzheimer's disease (AD) is the most common sporadic tauopathy. Although it is not caused by mutation in the microtubule-associated protein tau (MAPT) gene, previous studies showed that biomarkers of AD differ between patients with different MAPT genotypes. In this study, we tried to reveal whether the diagnostic potential of cerebrospinal fluid (CSF) biomarkers amyloid β1-42 (Aβ1-42), total tau (t-tau), tau phosphorylated at epitope 181 (p-tau181), epitope 199 (p-tau199), epitope 231 (p-tau231) and visinin-like protein 1 (VILIP-1) could be improved by MAPT haplotype-tagging polymorphisms (rs1467967, rs242557, rs3785883, rs2471738, del-In9, rs7521). First, we compared if levels of Aβ1-42, t-tau, p-tau181, p-tau199, p-tau231, and VILIP-1 differed between patients with different MAPT genotypes (rs1467967, rs242557, rs3785883, rs2471738, del-In9, rs7521). Second, we analyzed the distribution of MAPT haplotypes (H1 and H2 haplotypes and their sub-haplotypes) in Croatian population. Of the analyzed polymorphisms the del-In9 insertion-deletion in MAPT intron 9 defines the H1/H2 division caused by the inversion, while other single nucleotide polymorphisms (SNPs) define sub-haplotypes. The study was conducted on 113 AD and 53 mild cognitive impairment (MCI) patients, 9 healthy controls and 54 patients with other causes of dementia (14 with vascular dementia (VaD), 22 with frontotemporal dementia (FTD), 7 with dementia with Lewy bodies, 3 with AD + VaD, 1 with corticobasal syndrome (CBS), 2 with Parkinson disease (PD), 1 with epilepsy and 4 with unspecified dementia). Levels of t-tau were significantly higher in subjects with AG in comparison to GG rs1467967 tau genotype (when all patients were analyzed together). This observation was also confirmed in the combined group of AD, MCI patients and healthy controls. Differences in levels of CSF biomarkers between other MAPT genotypes (rs242557, rs3785883, rs2471738, del-In9, rs7521) were lost after Bonferroni correction for multiple comparisons. Additionally, we detected 23 H1 sub-haplotypes and 5 H2 sub-haplotypes in the Croatian population.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2014-09-9730 - Hiperfosforilacija, agregacija i transsinaptički prijenos tau proteina u Alzheimerovoj bolesti: analiza likvora i ispitivanje potencijalnih neuroprotektivnih spojeva (ALZTAUPROTECT) (Šimić, Goran) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Mirjana Babić Leko
(autor)
Goran Šimić
(autor)
Fran Borovečki
(autor)
Matea Nikolac Perković
(autor)
Nela Pivac
(autor)
Nataša Klepac
(autor)